(Q46873574)

English

The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1002/art.42546

The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

0 references

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

author name string

Tomás Trc

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Karel Karpas

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Petr Vítek

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Marie Sedlácková

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Vera Vlasáková

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Jana Böhmová

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Jozef Rovenský

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

publication date

1 December 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Arthritis & Rheumatology

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

56

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

4055-4064

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Radiological assessment of osteo-arthrosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Osteoarthritis: rational approach to treating the individual

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Measuring gain in the evaluation of medical technology. The probability of a better outcome

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Release of interleukin-1 from human synovial tissue in vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Diacerhein in the treatment of osteoarthritis of the hip

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Problems in measuring or interpreting change in patient outcomes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

The influence of rhein on the biosynthesis of prostaglandin-like substances in-vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Diacerein for osteoarthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Are cytokines involved in osteoarthritic pathophysiology?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/ART.23056

Identifiers

10.1002/ART.23056

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18050202

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46873574&oldid=2135400047"